Toby Maher, MD, PhD

USC
Los Angeles, CA, United States

Professor of Medicine and Director of the ILD Program at University of Southern California. I am an academic pulmonologist with an interest in ILD trials, biomarkers and disease mechanisms.

Disclosure information not submitted.

Presentation(s):

• 0003: Rituximab versus Cyclophosphamide for the Treatment of Connective Tissue Disease Associated Interstitial Lung Disease (RECITAL): A Sub-group Analysis of a Multi-centre Randomised Controlled Trial

  Saturday, November 12, 2022
  12:15 PM – 12:25 PM Eastern Time

• 541: CH Scleroderma: Wildcard - Targeting B Cells in SSc

  Saturday, November 12, 2022
  1:50 PM – 2:35 PM Eastern Time